The Global Companion Animal Health Market Size accounted for USD 19.6 Billion in 2021 and is projected to occupy a market size of USD 43.4 Billion by 2030 growing at a CAGR of 9.3% from 2022 to 2030.
Companion animals are the animals which serve man by giving brotherhood and guarding their homes or workplaces. Different sorts of sicknesses in creatures and their exchange to people by means of their item utilization and fellowship are raising the market all around.
Companion Animal Health Market Report Statistics
Global Companion Animal Health Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Companion Animal Health Market Report Coverage
Market | Companion Animal Health Market |
Companion Animal Health Market Size 2021 | USD 19.6 Billion |
Companion Animal Health Market Forecast 2030 | USD 43.4 Billion |
Companion Animal Health Market CAGR During 2022 - 2030 | 9.3% |
Companion Animal Health Market Analysis Period | 2018 - 2030 |
Companion Animal Health Market Base Year | 2021 |
Companion Animal Health Market Forecast Data | 2022 - 2030 |
Segments Covered | By Animal Type, By Product, By Distribution Channel, By End-Use, And By Geography |
Regional Scope | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
Key Companies Profiled | Agrolabo S.p.A., Bayer AG, Boehringer Ingelheim International GmbH, Ceva, Elanco, IDEXX Laboratories, Inc., Indian Immunologicals Ltd., Merck& Co., Nutreco N.V. Inc., Norbrook, Vetoquinol S.A., Virbac, and Zoetis. |
Report Coverage |
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis |
Companion Animal Health Market Growth Factors
Humanization has impacted the obtaining choices to a lot. In this manner, the changing impression of the buyers toward pet wellbeing and expanding pattern of the family unit is a couple of central point boosting the market development. With expanding family units pattern over the world has quickened the pet possession pattern and is required to keep amid the conjecture time frame. Throughout the years, the pattern of permeating pets with human attributes has expanded the wellbeing and security worries among pet proprietors. As indicated by an overview directed by the American Veterinary Medical Association, in the ongoing years, found that the use towards pet's wellbeing and veterinary consideration has seen an ascent by 40%. This ascent owes to the developing human-creature security, which characterizes customers' readiness to spend more cash for their pets. Further, the rising interest for pet medicinal services protection in the United States is relied upon to help this contention. Different variables driving the development of the market incorporate expanding web based shopping and home conveyance, cutting edge innovation in creature medicinal services, and expanding activities by government and creature welfare affiliations.
Companion Animal Health Market Segmentation
The global companion animal health market is segmented based on animal type, product, distribution channel, end-use, and geography.
Companion Animal Health Market By Animal Type
According to our companion animal health industry analysis, the dogs sub-segment accounted for more than 40% of the market in 2021 and is expected to maintain this trend in the coming years. The global affection for dogs, as well as the increasing adoption of dogs for security purposes, are the two major factors supporting the dog market share. Furthermore, rapidly increasing urbanization, raising awareness of pet health insurance, and the growing importance of animal health are all likely to support the industry's dog segment.
Companion Animal Health Market By Product
According to our companion animal health market forecast, pharmaceuticals are expected to hold significant market share from 2022 to 2030. On the other hand, pharmaceuticals sub-segment is likely to attain significant growth rate during the forecasted timeframe from 2022 to 2030. The increasing number of zoonotic diseases occurring in pets and the growth in research & development activities to diagnose these diseases will spur the diagnostics sub-segment.
Companion Animal Health Market By Distribution Channel
According to distribution channel, hospital pharmacies held the largest market share in 2021 and are expected to continue to do so in the coming years. The hospital pharmacies sub-segment is being driven by rising ease of access, a higher volume of prescriptions filled by these medical outlets, and an increase in demand for animal healthcare products. Furthermore, the increasing popularity of e-commerce will allow the market to expand even further in the coming years.
Companion Animal Health Market By End-Use
The veterinary hospitals & clinics sub-segment dominates the end-use segment due to a large number of patients that hospitals and clinics see. The variety of procedures performed at these facilities, such as general health exams, surgeries, and vaccinations, also contributes to the segment's expansion.
Companion Animal Health Market Regional Outlook
North America
Europe
Asia-Pacific
Latin America
The Middle East & Africa
Companion Animal Health Market Regional Analysis
In 2021, North America caught a significant piece of the overall industry, principally because of the nearness of conspicuous players undertaking broad development methodologies. In addition, expanding number of R&D speculations started by the organizations is one of the key potential components dared to be in charge of the size able offer gathered by the district. Moreover, expanding perpetual creature ailment load is foreseen to drive the tendency of specialists and social insurance experts toward cutting edge innovations, which thusly is additionally foreseen to extend the extension for development.
Companion Animal Health Market Players
The global Companion Animal Health market is characterized by the presence of experienced and established players. Some of the key players include Agrolabo S.p.A., Bayer AG, Boehringer Ingelheim International GmbH, Ceva, Elanco, IDEXX Laboratories, Inc., Indian Immunologicals Ltd., Merck& Co., Nutreco N.V. Inc., Norbrook, Vetoquinol S.A., Virbac, and Zoetis.
The market size of companion animal health market in 2021 was accounted to be USD 19.6 Billion.
The projected CAGR of companion animal health market during the analysis period of 2022 to 2030 is 9.3%.
The prominent players of the global companion animal health market include Agrolabo S.p.A., Bayer AG, Boehringer Ingelheim International GmbH, Ceva, Elanco, IDEXX Laboratories, Inc., Indian Immunologicals Ltd., Merck& Co., Nutreco N.V. Inc., Norbrook, Vetoquinol S.A., Virbac, and Zoetis.
North America held the dominating companion animal health during the analysis period of 2022 to 2030.
Asia-Pacific region exhibited fastest growing CAGR for companion animal health during the analysis period of 2022 to 2030.
Increasing companion ownership, growing prevalence of zoonotic diseases, and rising favorable government initiatives drives the growth of global companion animal health market.
Based on animal type, dogs segment is expected to hold the maximum share of the companion animal health market.